Bromocriptine in Patients with Peripartum Cardiomyopathy: Is there any benefit?

Author Information

David Murillo, Division of Cardiology, Department of Medicine, Reading Hospital-Tower Health, West Reading, PAFollow
Jaswanth R Jasti, Division of Cardiology, Department of Medicine, Reading Hospital-Tower Health, West Reading, PA
Nandini Razdan, Division of Cardiology, Department of Medicine, Reading Hospital-Tower Health, West Reading, PA
Rittu Hingorani, Division of Cardiology, Department of Medicine, Reading Hospital-Tower Health, West Reading, PA
Julian Diaz Fraga, Division of Cardiology, Department of Medicine, Reading Hospital-Tower Health, West Reading, PA

Keywords:

Peripartum cardiomyopathy, Bromocriptine, Retrospective cohort, Propensity score matching, All-cause mortality

Recommended Citation

Murillo, David; Jasti, Jaswanth R; Razdan, Nandini; Hingorani, Rittu; and Diaz Fraga, Julian, "Bromocriptine in Patients with Peripartum Cardiomyopathy: Is there any benefit?" (2025). Tower Health Research Day. 2.
https://scholarcommons.towerhealth.org/th_researchday/2024-2025/podium_presentations/2

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

Not Applicable